CRN comments on FDA NDI guidance
WASHINGTON — In regard to FDA issuing draft guidance on NDI notification master files for supplements today, CRN president and CEO Steve Mister offered the following comments on the development: “It’s a positive development to see the FDA moving ahead with this draft guidance. In 2020, CRN developed an NDI master file framework for